With contributions from experts drawn from academia, clinical practice, and the biotechnology and pharmaceutical industries, the book explores: Examining current hypotheses and suggesting possible new approaches to therapeutic clinical applications, this volume paves the way for a robust pipeline of therapeutics to combat not only AD, but a whole host of other neurodegenerative diseases.